Found 0 matching trials
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Show More Location
Federico II University Medical School
Learn More & Join Trial
Progesterone Supplementation After Letrozole-stimulated Insemination PHASE4 This trial aims to investigate whether luteal phase support improves the ch...
Show More Location
Copenhagen University Hospital - Rigshospitalet. Department of Gynecology, Fertility and Obstetrics
Learn More & Join Trial
Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI) PHASE2 This study is a primary investigation to determine the usefulness and safet...
Show More Location
Mount Sinai Hospital
Learn More & Join Trial
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) PHASE3 The study is intended to show superiority of AZD9833 in combination with CD...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer. NA Some tumors use estrogen in the body to assist with growth. Letrozole is a ...
Show More Location
Dartmouth Hitchcock Medical Center
Learn More & Join Trial
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer PHASE3 The study is a randomized, double blind, placebo controlled, Phase 3 clinic...
Show More Learn More & Join Trial
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor PHASE2 This study aimed at evaluating the safety and efficacy of everolimus plus e...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study) PHASE2 A phase II clinical trial designed to test the effect of combining endocrin...
Show More Location
Faculty of Medicine, Cairo University
Learn More & Join Trial
A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer PHASE3 The objective of this trial, DBCG R25, will be to evaluate the effect of tr...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors PHASE2 The purpose of this neoadjuvant trial is to evaluate efficacy and toxicity ...
Show More Status
Active Not Recruiting
Location
Department of Oncology, Karolinska University Hospital
Learn More & Join Trial